Results 31 to 40 of about 76,979 (321)

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

Lancet Global Health, 2020
Summary Background The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine serotype
N. Bar-Zeev, T. Swarthout, D. Everett, M. Alaerts, J. Msefula, C. Brown, Sithembile Bilima, J. Mallewa, Carina King, A. von Gottberg, J. Verani, C. Whitney, C. Mwansambo, S. Gordon, N. Cunliffe, N. French, R. Heyderman   +16 more
semanticscholar   +1 more source

Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey

Human Vaccines & Immunotherapeutics, 2017
Invasive pneumococcal infections among children are a serious public health problem in many countries, including Turkey. Pneumococcal conjugate vaccine has been included in Turkey's National Immunization Programme since 2009.
Ayşe Büyükcam, Hüseyin Güdücüoğlu, Kamuran Karaman, Venhar Gürbüz, Emil Aliyev, Ateş Kara, Mehmet Ceyhan   +6 more
doaj   +1 more source

Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001–2016

Pediatrics, 2020
Using population-based national surveillance data, we compared rates of IPD among children
T. Adebanjo, Tracy Pondo, D. Yankey, H. Hill, R. Gierke, M. Apostol, M. Barnes, S. Petit, M. Farley, L. Harrison, C. Holtzman, J. Baumbach, N. Bennett, S. McGuire, A. Thomas, W. Schaffner, B. Beall, C. Whitney, T. Pilishvili   +18 more
semanticscholar   +1 more source

Effect of pneumococcal conjugate vaccine six years post-introduction on pneumococcal carriage in Ulaanbaatar, Mongolia. [PDF]

Nat Commun
Limited data from Asia are available on long-term effects of pneumococcal conjugate vaccine introduction on pneumococcal carriage. Here we assess the impact of 13-valent pneumococcal conjugate vaccine (PCV13) introduction on nasopharyngeal pneumococcal ...
von Mollendorf C, Mungun T, Ulziibayar M, Skoko P, Boelsen L, Nguyen C, Batsaikhan P, Suuri B, Luvsantseren D, Narangerel D, Tsolmon B, Demberelsuren S, Ortika BD, Pell CL, Wee-Hee A, Nation ML, Hinds J, Dunne EM, Mulholland EK, Satzke C.   +19 more
europepmc   +2 more sources

Doubly Robust Proximal Synthetic Controls [PDF]

arXiv, 2022
To infer the treatment effect for a single treated unit using panel data, synthetic control methods construct a linear combination of control units' outcomes that mimics the treated unit's pre-treatment outcome trajectory. This linear combination is subsequently used to impute the counterfactual outcomes of the treated unit had it not been treated in ...
arxiv  

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

New England Journal of Medicine, 2015
BACKGROUND Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in adults 65 years of age or older is unknown. METHODS In a randomized, double-blind,
M. Bonten, S. Huijts, M. Bolkenbaas, Chris Webber, S. Patterson, S. Gault, C. H. van Werkhoven, A. V. van Deursen, E. Sanders, T. Verheij, Michael Patton, A. McDonough, A. Moradoghli-Haftvani, Helen M Smith, Tracey Mellelieu, M. Pride, Graham R. Crowther, B. Schmoele-Thoma, D. Scott, K. Jansen, R. Lobatto, B. Oosterman, Nils Visser, E. Caspers, Andre J. Smorenburg, E. Emini, W. Gruber, D. Grobbee   +27 more
semanticscholar   +1 more source

Beyond good intentions: lessons on equipment donation from an African hospital. [PDF]

, 2008
OBJECTIVE: In 2000, a referral hospital in the Gambia accepted a donation of oxygen concentrators to help maintain oxygen supplies. The concentrators broke down and were put into storage.
Adegbola, Richard A, Hill, Philip C, Hill, Sarah E, Howie, Stephen RC, Mulholland, Kim, Njie, Malick, Peel, David, Sanneh, Momodou   +7 more
core   +2 more sources

A brief history of and future prospects for pneumococcal vaccination in Malaysia

Pneumonia, 2023
Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme.
Alex J. J. Lister, Evelin Dombay, David W. Cleary, Lokman H. Sulaiman, Stuart C. Clarke   +4 more
doaj   +1 more source

The interactions of SARS-CoV-2 with co-circulating pathogens: Epidemiological implications and current knowledge gaps [PDF]

arXiv, 2022
Despite the availability of effective vaccines, the persistence of SARS-CoV-2 suggests that co-circulation with other pathogens and resulting multi-epidemics may become increasingly frequent. To better forecast and control the risk of such multi-epidemics, it is essential to elucidate the potential interactions of SARS-CoV-2 with other pathogens; these
arxiv  

Adesão às novas vacinas conjugadas. Vacina anti-meningocócica e anti-pneumocócica.

Acta Médica Portuguesa, 2004
The new conjugate vaccines against group C meningococcal infection and pneumococcal infection were introduced in Portugal in 2001. In 2001/2002, the media published several alarming news on meningococcal disease and there was an increased demand of those
Laurinda De Queirós, Luis Castro, Maria Carmo Ferreira, Guilherme Gonçalves   +3 more
doaj   +1 more source